COMPANY PROFILE

Gameto

Explore full profile

A new breed of biotechnology company focused on understanding and eliminating infertility and menopause

Bee Cave, United StatesFounded 2021Biotech & Life Sciences

Valuation $250–500M Last recorded · 2025

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Gameto

Gameto is a pioneering startup dedicated to transforming female reproductive health through innovative therapeutics. The company operates in the healthcare and biotechnology market, focusing on developing treatments that address critical aspects of women's reproductive health. Gameto's mission is to bring life-changing therapeutics to patients, aiming to redefine how female reproductive health issues are treated.

The company primarily serves women who are seeking advanced reproductive health solutions. This includes individuals undergoing fertility treatments, those looking to preserve their fertility, and women experiencing menopause. Gameto collaborates with leading fertility clinics and research institutions, such as Spring Fertility, Extend Fertility, and Eugin Group, to conduct studies and validate their therapeutic solutions.

Gameto's business model revolves around research and development (R&D) of novel therapeutics. They invest heavily in scientific research to create and refine their products, which are then brought to market through partnerships with healthcare providers. The company generates revenue by licensing their technologies and therapeutics to fertility clinics and other medical institutions. Additionally, they may earn income from direct sales of their products and potential collaborations with pharmaceutical companies.

In summary, Gameto is at the forefront of female reproductive health innovation, leveraging cutting-edge research to develop therapeutics that improve fertility outcomes and address menopause-related issues. Their commitment to scientific excellence and strategic partnerships positions them as a key player in the healthcare and biotechnology sectors.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Bee Cave, United States
Employees: 58
Open positions: 1
Dealroom signal: 89.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Fertility, Biotechnology, Spinout, Femtech, Biotech and Pharma, Menopause, Reproductive Health, Woman Founder, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Aug 2025	$44M	$176M	Bold Capital Partners · Pags Group · Overwater Ventures · Insight Partners	↗
SERIES BOther financing	May 2024	$33M	$132M	Chelsea M.R. Hirschhorn · Two Sigma Ventures · RA Capital Management · Insight Partners	↗

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Gameto website traffic

Latest recorded traffic for Gameto is 5.4K monthly website visits, up 14.9% over the last three months. Gameto's team grew 3.6% over the past year.

Latest monthly visits5.4K 3-month web change+14.9% 1-year team growth+3.6%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Medical DirectorMadrid, Spain · Other · Oct 28, 2025

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OXOxolifeDeveloping an innovative treatment to enhance female fertility success through acting on peri/post implementation process	Barcelona, Spain	Operational	5	$11M	$22M
MBMetri BioTherapeutics for endometrial diseases using 3D modeling	Boston, United States	Operational
REReproNovoAdvancing innovative therapeutic solutions for both male and female infertility, as well as pioneering treatment options for uterine conditions like adenomyosis	Lausanne, Switzerland	Operational
NTNotify TherapeuticsNon-hormonal fertility treatments activating dormant ovarian follicles	Copenhagen, Denmark	Operational
MTMuvon TherapeuticsMuvon Therapeutics is creating an autologous cell therapy for damaged skeletal muscles in SUI patients, with a primary focus on developing a safe treatment for stress urinary incontinence in women	Zurich, Switzerland	Operational
OLOverture LifeA biotechnology company that is aiming to revolutionize embryology	Alcobendas, Spain	Operational
TSTMRW Life SciencesProvides an integrated platform for automated, software-guided cryospecimen management	New York City, United States	Acquired
MPMithra PharmaceuticalsSpecialty biopharma developing estetrol-based women's health therapeutics	Liège, Belgium	Closed